These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 38603350)
21. New psychotropic medication use among Medicare beneficiaries with dementia after hospital discharge. Growdon ME; Gan S; Yaffe K; Lee AK; Anderson TS; Muench U; Boscardin WJ; Steinman MA J Am Geriatr Soc; 2023 Apr; 71(4):1134-1144. PubMed ID: 36514208 [TBL] [Abstract][Full Text] [Related]
22. Association between psychotropic prescriptions and the total amount of psychotropics ingested during an intentional overdose: A single-center retrospective study. Tanahashi I; Shiganami T; Iwayama T; Wake T; Kobayashi S; Yoshimasu H Neuropsychopharmacol Rep; 2022 Jun; 42(2):166-173. PubMed ID: 35174671 [TBL] [Abstract][Full Text] [Related]
23. Psychotropic Prescriptions During the COVID-19 Pandemic Among U.S. Children and Adolescents Receiving Mental Health Services. Amill-Rosario A; Lee H; Zhang C; dosReis S J Child Adolesc Psychopharmacol; 2022 Sep; 32(7):408-414. PubMed ID: 36067121 [No Abstract] [Full Text] [Related]
24. Effect of the COVID-19 pandemic on the psychotropic drug consumption. Benistand P; Vorilhon P; Laporte C; Bouillon-Minois JB; Brousse G; Bagheri R; Ugbolue UC; Baker JS; Flaudias V; Mulliez A; Dutheil F Front Psychiatry; 2022; 13():1020023. PubMed ID: 36590615 [TBL] [Abstract][Full Text] [Related]
25. Patterns and factors associated with the prescription of psychotropic medications after diagnosis of cancer in Chinese patients: A population-based cohort study. Lam CS; Lee CP; Chan JWY; Cheung YT Pharmacoepidemiol Drug Saf; 2024 Feb; 33(2):e5754. PubMed ID: 38362653 [TBL] [Abstract][Full Text] [Related]
26. [Profile of prescription of psychotropic drugs in a National Fund of Social Foresight Organisation in Morocco]. Belkacem A Encephale; 2006; 32(3 Pt 1):335-40. PubMed ID: 16840927 [TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetic and pharmacodynamic effects of psychotropic medications: Differences between sexes]. Bergiannaki JD; Kostaras P Psychiatriki; 2016; 27(2):118-26. PubMed ID: 27467032 [TBL] [Abstract][Full Text] [Related]
28. Comparative effectiveness of generic and brand-name medication use: A database study of US health insurance claims. Desai RJ; Sarpatwari A; Dejene S; Khan NF; Lii J; Rogers JR; Dutcher SK; Raofi S; Bohn J; Connolly JG; Fischer MA; Kesselheim AS; Gagne JJ PLoS Med; 2019 Mar; 16(3):e1002763. PubMed ID: 30865626 [TBL] [Abstract][Full Text] [Related]
29. [Autonomy attitudes in the treatment compliance of a cohort of subjects with continuous psychotropic drug administration]. Baumann M; Trincard M Encephale; 2002; 28(5 Pt 1):389-96. PubMed ID: 12386539 [TBL] [Abstract][Full Text] [Related]
30. Medicaid prescription limits: policy trends and comparative impact on utilization. Lieberman DA; Polinski JM; Choudhry NK; Avorn J; Fischer MA BMC Health Serv Res; 2016 Jan; 16():15. PubMed ID: 26772962 [TBL] [Abstract][Full Text] [Related]
31. Reasons for the Underutilization of Generic Drugs by US Ophthalmologists: A Survey. Dietze J; Priluck A; High R; Havens S Ophthalmol Ther; 2020 Dec; 9(4):955-970. PubMed ID: 32813159 [TBL] [Abstract][Full Text] [Related]
32. Discontinuation rates and health care costs in adult patients starting generic versus brand SSRI or SNRI antidepressants in commercial health plans. Vlahiotis A; Devine ST; Eichholz J; Kautzner A J Manag Care Pharm; 2011 Mar; 17(2):123-32. PubMed ID: 21348545 [TBL] [Abstract][Full Text] [Related]
33. Utilization of Generic Cardiovascular Drugs in Medicare's Part D Program. Ma I; Tisdale RL; Vail D; Heidenreich PA; Sandhu AT Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e007559. PubMed ID: 34879702 [TBL] [Abstract][Full Text] [Related]
34. Association of authorized generic marketing with prescription drug spending on antidepressants from 2000 to 2011. Cheng N; Banerjee T; Qian J; Hansen RA J Am Pharm Assoc (2003); 2017; 57(3):341-348. PubMed ID: 28400255 [TBL] [Abstract][Full Text] [Related]
35. Changes in prescribing of psychotropic vs some physical health medication in primary care through the COVID-19 pandemic in England: a national-level survey. Waheed U; Stedman M; Davies M; Solomon E; Taylor D; Heald A; Narayanan RP; Warner-Levy J J Pharm Policy Pract; 2023 Dec; 16(1):169. PubMed ID: 38124123 [TBL] [Abstract][Full Text] [Related]
36. Switching from brand-name to generic psychotropic medications: a literature review. Desmarais JE; Beauclair L; Margolese HC CNS Neurosci Ther; 2011 Dec; 17(6):750-60. PubMed ID: 21114789 [TBL] [Abstract][Full Text] [Related]
37. Shortages of antiseizure medications in Australia and the association with patient switching, and adherence in a community setting. Welton J; Stratton G; Schoeninger B; Low MH; Moody A; D'Souza W Epilepsy Behav; 2023 Apr; 141():109145. PubMed ID: 36913876 [TBL] [Abstract][Full Text] [Related]
38. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia. Doshi JA; Li P; Desai S; Marcus SC J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299 [TBL] [Abstract][Full Text] [Related]
39. Drug-Drug Interactions Between COVID-19 Treatments and Psychotropic Medications: An Updated Study. Boppana U; Leonard TS; Jolayemi A; Ansari MI; Salib A Cureus; 2023 Dec; 15(12):e50469. PubMed ID: 38222143 [TBL] [Abstract][Full Text] [Related]
40. Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study. Grundy Q; Quanbury A; Hart D; Chaudhry S; Tavangar F; Lexchin J; Gagnon MA; Tadrous M CMAJ; 2023 Nov; 195(46):E1565-E1576. PubMed ID: 38011930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]